Core Insights - The article highlights the performance of various actively managed equity funds under the management of experienced fund managers at FuGuo Fund, showcasing their ability to navigate market volatility and achieve strong returns across different time frames [1][27]. Group 1: Fund Performance - Several funds managed by FuGuo Fund have ranked in the top 10% of their peers over various time periods, indicating strong performance and effective management strategies [1][42]. - The FuGuo ZhongXiaoPan Selected Mixed Fund (A Class 000940) has consistently ranked in the top 1% over the past 10 years, demonstrating exceptional long-term performance [4][48]. - The FuGuo Medical Innovation Stock Fund (A Class 019916) achieved the top rank in its category over the past year, reflecting successful investment strategies in the healthcare sector [31][42]. Group 2: Manager Expertise - Cao Jin, with over 16 years of experience, has successfully managed funds focusing on technology and new energy sectors, achieving top rankings across multiple time frames [3][4]. - Yang Dong, another experienced manager, has demonstrated strong performance in growth stocks and has maintained a balanced investment approach, with several funds ranking in the top 10% [8][9]. - New generation managers like Xu Zhixiang and Sun Quan have also shown impressive results, with their funds ranking highly in the new materials and emerging industries sectors [19][22]. Group 3: Sector Focus - The article emphasizes the importance of sector-specific strategies, with managers focusing on technology, healthcare, and consumer sectors to capture growth opportunities [27][33]. - FuGuo Fund's investment in the healthcare sector, particularly through the FuGuo Medical Innovation Stock Fund, highlights the potential for innovation-driven returns in this field [31][32]. - The consumer sector remains a core focus, with managers adept at identifying companies with sustainable competitive advantages amid changing market dynamics [33][35]. Group 4: Global Investment - FuGuo Fund's overseas investment team leverages extensive cross-border investment experience to identify global opportunities, with notable performance in international equity funds [39][40]. - The FuGuo Blue Chip Selected Stock Fund (QDII) has ranked second among its peers, showcasing the effectiveness of its global investment strategy [39][42].

Core Viewpoint - The recent resignation of star fund manager Yu Yang from two funds managed by Wutong Fund has sparked significant industry attention, raising concerns about the career paths of star fund managers, talent mobility in the public fund industry, and performance pressures [1][6]. Group 1: Manager Resignation - Yu Yang's resignation was anticipated, as he had been gradually stepping back from managing his funds since March, with co-managers being appointed to both funds prior to his departure [2][6]. - After his resignation, the management of the funds will be taken over by Lin Qing and Zhang Hong, respectively [2]. Group 2: Career Background - Yu Yang began his career in 2011, combining academic and practical experience, with a strong background in pharmaceutical investment [3]. - He joined Wutong Fund in 2015 and achieved remarkable returns, including a 138.63% return on the Wutong New Power Flexible Allocation Mixed Fund during his initial management period [3][4]. Group 3: Performance Issues - Following his return to Wutong Fund in December 2021, Yu Yang's performance did not meet market expectations, with a cumulative loss of 11.29% during his management of the Wutong New Power fund [5]. - The management scale of his funds significantly decreased, from 76.60 billion yuan to 40.74 billion yuan, indicating a near halving of assets under management [5]. Group 4: Industry Trends - Yu Yang's departure reflects a broader trend in the public fund industry, where the number of fund manager resignations has increased, indicating deeper changes within the industry [7]. - The industry is moving away from reliance on star fund managers towards a more team-based and platform-oriented investment research system, as emphasized by regulatory guidance [7][8].